MatchMiner: an open-source platform for cancer precision medicine
Abstract Widespread, comprehensive sequencing of patient tumors has facilitated the usage of precision medicine (PM) drugs to target specific genomic alterations. Therapeutic clinical trials are necessary to test new PM drugs to advance precision medicine, however, the abundance of patient sequencin...
| 出版年: | npj Precision Oncology |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Nature Portfolio
2022-10-01
|
| オンライン・アクセス: | https://doi.org/10.1038/s41698-022-00312-5 |
